About Choice Therapeutics
Choice Therapeutics is a company based in Wrentham (United States) founded in 2006 was acquired by Alliqua in May 2014.. Choice Therapeutics has raised $1.95 million across 2 funding rounds from investors including Alliqua. Choice Therapeutics operates in a competitive market with competitors including QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.
- Headquarter Wrentham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Choice Therapeutics
Choice Therapeutics has successfully raised a total of $1.95M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $582 thousand completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $582,000
-
First Round
First Round
(02 Jul 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2011 | Amount | Seed - Choice Therapeutics | Valuation |
investors |
|
| Jul, 2009 | Amount | Seed - Choice Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Choice Therapeutics
Choice Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Alliqua. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wound care solutions through transdermal drug delivery
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Choice Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Choice Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Choice Therapeutics Comparisons
Competitors of Choice Therapeutics
Choice Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| domain | founded_year | HQ Location |
Powdered fibrin sealant for surgical bleeding
|
|
| domain | founded_year | HQ Location |
Topical formulations for corneal wounds, ulcers, and scars are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Choice Therapeutics
When was Choice Therapeutics founded?
Choice Therapeutics was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Where is Choice Therapeutics located?
Choice Therapeutics is headquartered in Wrentham, United States. It is registered at Wrentham, Massachusetts, United States.
Who is the current CEO of Choice Therapeutics?
Jim Hutchens is the current CEO of Choice Therapeutics.
Is Choice Therapeutics a funded company?
Choice Therapeutics is a funded company, having raised a total of $1.95M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.37M, raised on Jul 02, 2009.
What does Choice Therapeutics do?
Choice Therapeutics manufactures wound care products for burns, advanced wound care, and surgical site infections. It offers TheraBond 3D Contact Dressings used as contact layers for wounds; TheraBond 3D Wraps used as contact dressings configured in a bandage wrap design; and TheraBond 3D Island Dressings for incisions. TheraBond 3D provides infection prevention and protection in a variety of post-op scenarios such as Cardiothoracic surgery, Vascular surgery, Orthopedic surgery, Foot and ankle surgery and others. As of May 5, 2014, Choice Therapeutics operates as a subsidiary of Alliqua Biomedical.
Who are the top competitors of Choice Therapeutics?
Choice Therapeutics's top competitors include Ilya Pharma, QBiotics and Tempo Therapeutics.
Who are Choice Therapeutics's investors?
Choice Therapeutics has 1 investor. Key investors include Alliqua.